Shaojun Lin

机构：Fujian Medical University, Fujian Provincial Cancer Hospital · ORCID：0000-0001-7164-9761

发表论文 72 篇 · 总被引 1612 次 · h-index 21

代表论文

• The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma (2021 · 癌症：英文版 · 被引 413)
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial (2025 · Cancer Cell · 被引 40)
• High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma (2021 · Frontiers in Oncology · 被引 31)
• Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series (2021 · Radiotherapy and Oncology · 被引 29)
• Autocrine INSL5 promotes tumor progression and glycolysis via activation of STAT5 signaling (2020 · EMBO Molecular Medicine · 被引 24)
• International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version) (2025 · International Journal of Radiation Oncology*Biology*Physics · 被引 20)